Advanced Medical Solutions — Shareholder Meeting (May 2023)

4 slides from Advanced Medical Solutions's shareholder meeting presentation, May 31, 2023

Slide 1: Advanced Medical Solutions Annual General Meeting
Advanced Medical Solutions Annual General Meeting – Chris Meredith (CEO) 31 May 2023 11
Slide 2: Financial Highlights
Financial Highlights Continued, strong revenue growth, profit and cash generation • 2022 trading remained strong despite increasing macro-economic challenges • Revenue increased 10%* to £124.3 million (2021: £108.6 million) • Adjusted profit before tax up 11% to £28.5 million (2021: £25.6 million) •
Slide 3: Operational Highlights
Operational Highlights Regulatory and clinical progress as investment continues in next-generation products • PMA for LiquiBand Fix8® submitted and accepted by FDA, approval anticipated at the end of 2023 • US approval of LiquiBand® XL H1 2022, US launch progressing well with initial orders fulfille
Slide 4: Summary and Outlook
Summary and Outlook Delivering strong performance from key businesses while maintaining focus on new products • AMS continued to generate strong revenue and profit growth in 2022 in line with expectations • Significant clinical and regulatory progress being made as the Group continues to invest in i